# Bicycle Therapeutics plc: filings

BCYC · Nasdaq · CIK 1761612 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcyc.md) · [Financials](/companies/bcyc/financials.md) · [Filings](/companies/bcyc/filings.md) · [Insiders](/companies/bcyc/insiders.md)

## Reports and events: 146 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 250, 8-K 94, 144 85, 3 36, 10-Q 23, SC 13G/A 20, SCHEDULE 13G/A 13, S-8 11, SC 13G 11, 4/A 9, CORRESP 8, 10-K 7, 424B5 7, DEF 14A 7, SC 13D/A 7, SCHEDULE 13G 7, PRE 14A 6, UPLOAD 6, SC 13D 5, 3/A 4, ARS 4, EFFECT 4, DEFA14A 3, S-1/A 2, S-3 2, S-3ASR 2, 424B3 1, 424B4 1, 424B7 1, 8-A12B 1, CERT 1, CT ORDER 1, D 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:12 ET | [10-Q](/filings/0001104659-26-119864.md) | Quarterly report, period 2026-09-30 | 0001104659-26-119864 |
| 2026-10-29 | 07:05 ET | [8-K](/filings/0001104659-26-119858.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-119858 |
| 2026-08-20 | 16:05 ET | [8-K](/filings/0001104659-26-099221.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-099221 |
| 2026-07-30 | 07:10 ET | [10-Q](/filings/0001104659-26-088457.md) | Quarterly report, period 2026-06-30 | 0001104659-26-088457 |
| 2026-07-30 | 07:05 ET | [8-K](/filings/0001104659-26-088455.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-088455 |
| 2026-06-18 | 08:21 ET | [8-K](/filings/0001104659-26-075451.md) | 5.07 Shareholder vote results | 0001104659-26-075451 |
| 2026-05-21 | 17:05 ET | [8-K](/filings/0001104659-26-065231.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065231 |
| 2026-04-30 | 07:10 ET | [10-Q](/filings/0001104659-26-052117.md) | Quarterly report, period 2026-03-31 | 0001104659-26-052117 |
| 2026-04-30 | 07:05 ET | [8-K](/filings/0001104659-26-052107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-052107 |
| 2026-04-22 | 16:05 ET | [DEF 14A](/filings/0001104659-26-046806.md) | Proxy statement, period 2026-06-17 | 0001104659-26-046806 |
| 2026-04-20 | 07:06 ET | [8-K](/filings/0001104659-26-045198.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-045198 |
| 2026-03-17 | 07:19 ET | [10-K](/filings/0001104659-26-028971.md) | Annual report, period 2025-12-31 | 0001104659-26-028971 |
| 2026-03-17 | 07:05 ET | [8-K](/filings/0001104659-26-028954.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-028954 |
| 2026-02-03 | 07:07 ET | [8-K](/filings/0001104659-26-009501.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-009501 |
| 2026-01-12 | 07:12 ET | [8-K](/filings/0001104659-26-002706.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002706 |
| 2025-10-30 | 07:16 ET | [10-Q](/filings/0001104659-25-104010.md) | Quarterly report, period 2025-09-30 | 0001104659-25-104010 |
| 2025-10-30 | 07:05 ET | [8-K](/filings/0001104659-25-104004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-104004 |
| 2025-09-08 | 16:01 ET | [8-K](/filings/0001104659-25-088238.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-088238 |
| 2025-08-08 | 07:14 ET | [10-Q](/filings/0001558370-25-010843.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010843 |
| 2025-08-08 | 07:05 ET | [8-K](/filings/0001104659-25-075435.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-075435 |
| 2025-06-17 | 17:08 ET | [8-K](/filings/0001104659-25-060316.md) | 5.07 Shareholder vote results | 0001104659-25-060316 |
| 2025-05-01 | 07:10 ET | [10-Q](/filings/0001558370-25-006049.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006049 |
| 2025-05-01 | 07:05 ET | [8-K](/filings/0001104659-25-043014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-043014 |
| 2025-04-29 | 07:22 ET | [8-K](/filings/0001104659-25-040625.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-040625 |
| 2025-04-23 | 16:03 ET | [DEF 14A](/filings/0001558370-25-005258.md) | Proxy statement, period 2025-06-17 | 0001558370-25-005258 |
| 2025-03-27 | 08:02 ET | [8-K](/filings/0001104659-25-028531.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-028531 |
| 2025-03-14 | 16:01 ET | [8-K](/filings/0001104659-25-023934.md) | 5.08 Item not in the standard list | 0001104659-25-023934 |
| 2025-02-25 | 07:27 ET | [10-K](/filings/0001558370-25-001438.md) | Annual report, period 2024-12-31 | 0001558370-25-001438 |
| 2025-02-25 | 07:05 ET | [8-K](/filings/0001104659-25-016709.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-016709 |
| 2025-01-13 | 16:01 ET | [8-K](/filings/0001104659-25-003026.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-003026 |
| 2024-12-17 | 18:46 ET | [SC 13D/A](/filings/0001104659-24-129475.md) | Ownership report, active investor, amended | 0001104659-24-129475 |
| 2024-12-13 | 09:15 ET | [8-K](/filings/0001104659-24-128241.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-128241 |
| 2024-10-31 | 07:20 ET | [10-Q](/filings/0001558370-24-014004.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014004 |
| 2024-10-31 | 07:05 ET | [8-K](/filings/0001104659-24-112848.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-112848 |
| 2024-10-23 | 09:01 ET | [8-K](/filings/0001104659-24-110749.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-110749 |
| 2024-09-19 | 08:00 ET | [8-K](/filings/0001104659-24-101202.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-101202 |
| 2024-08-06 | 07:40 ET | [10-Q](/filings/0001558370-24-010949.md) | Quarterly report, period 2024-06-30 | 0001558370-24-010949 |
| 2024-08-06 | 07:05 ET | [8-K](/filings/0001104659-24-086085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086085 |
| 2024-07-10 | 16:50 ET | [8-K](/filings/0001104659-24-078976.md) | 1.02 Termination of a material agreement | 0001104659-24-078976 |
| 2024-06-18 | 16:18 ET | [8-K](/filings/0001104659-24-072828.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-072828 |
| 2024-05-28 | 16:16 ET | [SC 13D/A](/filings/0001104659-24-065602.md) | Ownership report, active investor, amended | 0001104659-24-065602 |
| 2024-05-23 | 16:26 ET | [8-K](/filings/0001104659-24-064716.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-064716 |
| 2024-05-16 | 16:01 ET | [8-K](/filings/0001104659-24-062503.md) | 5.07 Shareholder vote results | 0001104659-24-062503 |
| 2024-05-02 | 07:15 ET | [10-Q](/filings/0001558370-24-006453.md) | Quarterly report, period 2024-03-31 | 0001558370-24-006453 |
| 2024-05-02 | 07:06 ET | [8-K](/filings/0001104659-24-055981.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-055981 |
| 2024-04-18 | 07:29 ET | [SC 13D](/filings/0001104659-24-048601.md) | Ownership report, active investor | 0001104659-24-048601 |
| 2024-04-18 | 07:00 ET | [8-K](/filings/0001104659-24-048576.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-048576 |
| 2024-04-15 | 16:05 ET | [DEF 14A](/filings/0001558370-24-005119.md) | Proxy statement, period 2024-05-16 | 0001558370-24-005119 |
| 2024-02-20 | 07:19 ET | [10-K](/filings/0001558370-24-001324.md) | Annual report, period 2023-12-31 | 0001558370-24-001324 |
| 2024-02-20 | 07:05 ET | [8-K](/filings/0001104659-24-025196.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-025196 |

Page 1 of 3. [Older](/companies/bcyc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:25 ET. No prices; not investment advice.